McNeil Seeks Supreme Court Opinion On OTC Labeling Pre-emption
This article was originally published in The Pink Sheet Daily
The Johnson & Johnson subsidiary is asking the court to weigh in on the issue by taking up McNeil v. Valdes, in which McNeil appeals a ruling by the Third District Court of Appeal of Florida.
You may also be interested in...
The U.S. Supreme Court will address the controversial question of whether states can restrict the use of physician prescribing information.
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.